ATLANTA, GA – – (Newsfile Corp. – February 4, 2021) – – Holzer & Holzer, LLC is investigating whether Clover Health Investments, Corp. (“Clover” or the “Company”) (NASDAQ: CLOV) complied with federal securities laws. On February 4, 2021, Hindenburg Research published a report stating that it had obtained a copy of a DOJ Civil Investigative Report seeking testimony in connection with an investigation into “whether Clover Health Investment Corporation and/or related entities improperly induced patient referrals for services paid for by Federal agencies.” The price of Clover’s stock fell following the announcement. If you purchased shares of Clover and suffered a loss on that investment, you are encouraged to contact Marshall P. Dees, Esq. at mdees@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights or at www.holzerlaw.com.